ICU Medical (ICUI) Tops Q2 EPS by 60c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mail
Get Alerts ICUI Hot Sheet
Price: $160.84 -0.15%
Revenue Growth %: +2.8%
Financial Fact:
NET INCOME: 18.81M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Revenue Growth %: +2.8%
Financial Fact:
NET INCOME: 18.81M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
ICU Medical (NASDAQ: ICUI) reported Q2 EPS of $2.10, $0.60 better than the analyst estimate of $1.50. Revenue for the quarter came in at $548.9 million versus the consensus estimate of $540.1 million.
GUIDANCE:
ICU Medical sees Q3 2025 EPS of ($1.68)-($1.38), versus the consensus of $1.49.
For earnings history and earnings-related data on ICU Medical (ICUI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pharming Group N.V. (PHAR) Reports Q3 results; offers guidance
- JPMorgan Downgrades Opmobility SE (OPM:FP) to Neutral
- JPMorgan Upgrades Ageas (AGS:BB) (AGESY) to Overweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
